The ASCVD Risk Calculator (ACC/AHA) estimates 10-year risk of atherosclerotic cardiovascular disease from age, sex, race, cholesterol levels, blood pressure, diabetes, and smoking status. Applies the 2013 Pooled Cohort Equations to guide statin therapy decisions in primary prevention.
5.7
%
0
1
0
0
5.7
%
0
1
0
0
Should this patient start a statin? For primary prevention — patients who have never had a heart attack or stroke — that decision turns on a 10-year ASCVD risk estimate. The calculator for ACC/AHA ASCVD risk applies the Pooled Cohort Equations (PCE) to compute the 10-year probability of a first atherosclerotic event (heart attack or stroke), providing the quantitative foundation for the shared decision-making conversation between clinician and patient.
The 2013 ACC/AHA Pooled Cohort Equations estimate the 10-year risk of a first atherosclerotic cardiovascular event — defined as nonfatal myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke. The equation uses sex- and race-specific coefficients applied to:
The equations were derived from five community-based prospective cohorts (ARIC, CHS, CARDIA, Framingham Original, and Framingham Offspring) — the largest primary prevention dataset used for a cardiovascular risk equation at the time. The Framingham Risk Score calculator provides the predecessor equation for comparison.
The 2018 ACC/AHA Cholesterol Guideline uses the 10-year ASCVD risk to guide statin recommendations:
Risk-enhancing factors that shift borderline-risk patients toward treatment include: family history of premature ASCVD, LDL-C ≥160 mg/dL, chronic kidney disease, metabolic syndrome, inflammatory conditions (rheumatoid arthritis, psoriasis, HIV), and South Asian ancestry. Use this online calculator for the initial risk estimate before applying these modifiers.
The Pooled Cohort Equations have been criticized for systematically overestimating risk in certain populations, particularly in lower-risk contemporary cohorts where improved medications have reduced event rates below historical levels. Studies have found the PCE overestimate risk by 75–150% in some validation cohorts. The race-specific equations (separate calculations for White and Black patients, with Black patients generally receiving higher risk estimates) have generated ongoing debate about the appropriateness of race as a biological variable in risk models, leading to work on race-free alternatives. The 2023 Predicting Risk of CVD EVENTs (PREVENT) equations address some of these limitations. The atherogenic index calculator and cardiovascular risk calculators provide complementary lipid and cardiovascular assessment tools.
For patients in the borderline risk zone (5–20%) where the treatment decision is uncertain, the ACC/AHA guidelines recommend considering coronary artery calcium (CAC) scoring as a tie-breaker. CAC = 0 supports deferring statin therapy (very low near-term risk despite elevated traditional risk factors); CAC ≥100 Agatston units or ≥75th percentile for age/sex strongly favors statin initiation. CAC scoring is a CT scan that detects calcified coronary plaque — the best available noninvasive marker of subclinical atherosclerosis — and reclassifies approximately 30% of borderline-risk patients to either lower or higher risk categories.
The calculator uses the ACC/AHA Pooled Cohort Equations, which are Cox proportional hazards models with sex- and race-specific coefficients. Logarithmic transformations of age, total cholesterol, HDL cholesterol, and systolic blood pressure are multiplied by their respective coefficients, with additional terms for interaction effects (age x cholesterol, age x HDL, age x smoking, age x blood pressure). The weighted sum is then applied to the baseline survival function to produce a 10-year risk probability.
A 10-year ASCVD risk below 5% is considered low risk. Between 5-7.5% is borderline risk where risk-enhancing factors may influence treatment decisions. Between 7.5-20% is intermediate risk, typically warranting moderate-intensity statin therapy after clinician-patient discussion. Risk at or above 20% is high, indicating clear benefit from high-intensity statin therapy. These thresholds guide but do not replace clinical judgment and shared decision-making.
Inputs
Results
This patient falls in the intermediate risk category, where moderate-intensity statin therapy is typically recommended.
Inputs
Results
This low-risk patient would typically be managed with lifestyle interventions rather than pharmacological therapy.
Atherosclerotic Cardiovascular Disease (ASCVD) includes conditions caused by atherosclerosis: coronary heart disease (heart attacks), cerebrovascular disease (strokes), and peripheral arterial disease. It is the leading cause of death globally, accounting for approximately 17.9 million deaths annually.
The ASCVD Risk Calculator is designed for adults aged 40-79 without existing cardiovascular disease. It is used in primary prevention to guide decisions about statin therapy and lifestyle interventions. Patients with established ASCVD require secondary prevention strategies regardless of calculated risk.
Low risk: less than 5% (lifestyle modifications). Borderline risk: 5-7.5% (consider risk-enhancing factors). Intermediate risk: 7.5-20% (moderate-intensity statin recommended). High risk: 20% or greater (high-intensity statin recommended). These thresholds are from the 2018 ACC/AHA cholesterol guidelines.
The Pooled Cohort Equations include specific models for White and African American individuals. For other racial/ethnic groups, the White equations are used as the best available estimate, though accuracy may be reduced. Research is ongoing to develop and validate equations for additional populations.
Yes, several studies have shown the Pooled Cohort Equations may overestimate risk in some populations, including lower-risk groups and certain ethnic groups. The 2018 guidelines address this by recommending coronary artery calcium (CAC) scoring to reclassify borderline and intermediate-risk patients.
Risk-enhancing factors include family history of premature ASCVD, LDL-C persistently above 160 mg/dL, metabolic syndrome, chronic kidney disease, chronic inflammatory conditions (e.g., rheumatoid arthritis, psoriasis), history of preeclampsia or premature menopause, South Asian ancestry, and elevated biomarkers (Lp(a), apoB, hsCRP, ABI).
The calculator uses different coefficients for treated versus untreated blood pressure. At the same systolic blood pressure reading, a treated patient may have a slightly different risk estimate than an untreated patient, reflecting the additional risk associated with hypertension requiring pharmacological treatment.
No. This calculator is for primary prevention only. Patients with established ASCVD (prior heart attack, stroke, stent, bypass, or peripheral arterial disease) are considered very high risk and should receive high-intensity statin therapy and comprehensive secondary prevention regardless of calculated risk scores.
The ACC/AHA recommends reassessing cardiovascular risk every 4-6 years for adults aged 40-75. More frequent reassessment may be appropriate when risk factors change significantly, such as new diabetes diagnosis, smoking cessation, or significant changes in cholesterol or blood pressure levels.
Coronary Artery Calcium (CAC) scoring uses a non-contrast CT scan to detect calcified plaque in the coronary arteries. A CAC score of zero indicates very low near-term risk and may downgrade risk in borderline/intermediate patients. A high CAC score suggests subclinical atherosclerosis and may upgrade risk classification, especially useful for refining treatment decisions in intermediate-risk patients.
How helpful was this calculator?
Be the first to rate!
Carb Calculator
Macronutrient & Micronutrient Calculators
Fat Intake Calculator
Macronutrient & Micronutrient Calculators
Fiber Calculator
Macronutrient & Micronutrient Calculators
Micronutrient Calculator
Macronutrient & Micronutrient Calculators
Vitamin Calculator
Macronutrient & Micronutrient Calculators
Step to Miles Converter
Exercise & Performance Calculators
